Anonymous ID: 088433 May 20, 2022, 3:12 a.m. No.16309042   🗄️.is 🔗kun   >>9051 >>9088 >>9113 >>9185 >>9271 >>9339 >>9342

>>16309034

 

Notable

 

BavarianNordic Monkeypox Vaccine

 

Website: https://www.bavarian-nordic.com/investor/news/news.aspx?news=6569

 

BAVARIAN NORDIC TO MANUFACTURE FIRST FREEZE-DRIED DOSES OF SMALLPOX VACCINE UPON EXERCISE OF CONTRACT OPTION BY THE U.S. GOVERNMENT

USD 119 million option exercised for the manufacturing of freeze-dried JYNNEOS® in 2023 and 2024

This represents the first set of options with a total value of USD 299 million to convert the existing bulk vaccine, previously purchased by BARDA, to approximately 13 million freeze-dried JYNNEOS doses

Anonymous ID: 088433 May 20, 2022, 3:17 a.m. No.16309063   🗄️.is 🔗kun   >>9070 >>9088 >>9111

>>16309041

 

Poxvirus vectors encoding HIV antigens, and methods of use thereof

 

U.S. patent number 11,229,693 [Application Number 16/620,669] was granted by the patent office on 2022-01-25 for poxvirus vectors encoding hiv antigens, and methods of use thereof. This patent grant is currently assigned to Bavarian Nordic A/S, Janssen Vaccines & Prevention B.V.. The grantee listed for this patent is Bavarian Nordic A/S, Janssen Vaccines & Prevention B.V.. Invention is credited to Viki Bockstal, Jerome Hubertina Henricus Victor Custers, Markus Kalla, Johannes Petrus Maria Langedijk, Frank Wegmann.

 

https://uspto.report/patent/grant/11,229,693